Croda teams up with Aquapharm to utilise marine microbes for skin care

By Andrew McDougall

- Last updated on GMT

Related tags Biotechnology Cosmetics Croda

Marine biotechnology company Aquapharm Biodiscovery has signed a research and development agreement with specialty chemicals company Croda to develop a range of skin care products from marine microbes.

Having signed an initial research contract with Yorkshire-based Croda in 2008, the Scottish biotech firm has now struck a new deal with its cosmetics subsidiary Sederma, with plans for the first of these products to be released in 2013.

Croda Enterprise Technology president, Dr Keith Layden commented: “Aquapharm is one of the UK’s most promising biotech firms. Our collaboration thus far has led to many exciting new developments which promise to deliver novel and sustainable solutions for the personal care industry.”

“We are excited to now be able to bring all of that research to bear through our subsidiary, Sederma, which is dedicated to the development of active ingredients for the cosmetics industry.”

Crucial stage of development

For Aquapharm this is a crucial stage in the development of next generation cosmetics using its collection of micro-organisms.

Prof. Simon Best, CEO, told “Croda is now going ahead with 12 candidate products that have been extensively tested against pharmaceutical-type screens, all of which have been identified as having either anti-inflammatory or antioxidant qualities, or even both.”

The previous collaboration between the two companies was to conduct research to screen a large number of marine-sourced fermentation extracts in Aquapharm’s collection.

“This work was successful and led to the selection of the candidate products which will be taken further in the new collaboration which moves from the research to development and scale-up phase,”​ added Best.

“This deal puts us on course to see the first products launched to market as early as 2013. We can’t be sure that all 12 of the candidate products will reach the market-place but we can be sure that some exciting ones will so this is a major step forward for us,”​ he said.

Marine microbes catching the eye

And Best explained that the deal with Sederma shows that large companies are now taking stock of the ‘next generation’ cosmetics products such as marine microbes.

“Croda is one of the few companies in the world that takes natural ingredients like Aquapharm’s and makes them into products, which have the potential to then be taken up by companies such as Procter & Gamble and L’Oreal.”

Best added that Aquapharm expects to conclude further collaborations with personal care, nutrition and beverage partners in the near future.

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us


View more



Beauty 4.0 Podcast